Mark C. Poznansky

11.1k total citations · 4 hit papers
111 papers, 6.6k citations indexed

About

Mark C. Poznansky is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Mark C. Poznansky has authored 111 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Immunology, 34 papers in Oncology and 28 papers in Infectious Diseases. Recurrent topics in Mark C. Poznansky's work include Immunotherapy and Immune Responses (25 papers), Chemokine receptors and signaling (18 papers) and T-cell and B-cell Immunology (16 papers). Mark C. Poznansky is often cited by papers focused on Immunotherapy and Immune Responses (25 papers), Chemokine receptors and signaling (18 papers) and T-cell and B-cell Immunology (16 papers). Mark C. Poznansky collaborates with scholars based in United States, United Kingdom and China. Mark C. Poznansky's co-authors include Ivona T. Olszak, Fabrizio Vianello, A. John Iafrate, Alejandro B. Balazs, David J. Gregory, Kerri St. Denis, Jared Feldman, Vivek Naranbhai, Adam D. Nitido and Evan C. Lam and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark C. Poznansky

105 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

2021 849 citations Wilfredo F. García-Beltrán, Evan C. Lam et al. profile →
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

2012 828 citations Elda Righi, Michael Santosuosso et al. profile →
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

2022 651 citations Wilfredo F. García-Beltrán, Kerri St. Denis et al. profile →
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor

2005 549 citations Gregor B. Adams, Douglas P. Olson et al. profile →

Peers

Countries citing papers authored by Mark C. Poznansky

Since Specialization

Citations

This map shows the geographic impact of Mark C. Poznansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Poznansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Poznansky more than expected).

Fields of papers citing papers by Mark C. Poznansky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Poznansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Poznansky. The network helps show where Mark C. Poznansky may publish in the future.

Co-authorship network of co-authors of Mark C. Poznansky

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Poznansky. A scholar is included among the top collaborators of Mark C. Poznansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Poznansky. Mark C. Poznansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity 2024 ·Cell Reports Medicine ·Alex Roederer, (unknown), Kerri St. Denis, Maegan L. Sheehan, (unknown), Evan C. Lam, David J. Gregory, Mark C. Poznansky, A. John Iafrate, David H. Canaday, Stefan Gravenstein, Wilfredo F. García-Beltrán, Alejandro B. Balazs	1
2	B cell treatment promotes a neuroprotective microenvironment after traumatic brain injury through reciprocal immunomodulation with infiltrating peripheral myeloid cells 2023 ·Journal of Neuroinflammation ·(unknown), (unknown), (unknown), Mark C. Poznansky, Michael J. Whalen, Ruxandra F. Sîrbulescu	13
3	The 2022 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, March 30, 2022 2022 ·The FASEB Journal ·(unknown), Ann Stowe, Kristian P. Doyle, Phillip G. Popovich, Elizabeth B. Engler-Chiurazzi, Christian LeGuern, Marion S. Buckwalter, Mark C. Poznansky, Ruxandra F. Sîrbulescu	1
4	Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo 2022 ·Science Advances ·James A. Torchia, Alexander H. Tavares, (unknown), Da‐Yuan Chen, Jessie Huang, Tianshu Xiao, (unknown), Patrick M. Reeves, Hua Tu, Ann E. Sluder, Bing Chen, Darrell N. Kotton, Richard A. Bowen, Mohsan Saeed, Mark C. Poznansky, Gordon J. Freeman	14
5	Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity 2022 ·Frontiers in Immunology ·Ann E. Sluder, Susan Raju Paul, Leonard Moise, Christina Dold, Guilhem Richard, Laura Silva-Reyes, Laurie A. Baeten, Anja Scholzen, Patrick M. Reeves, Andrew J. Pollard, Anja Garritsen, Richard A. Bowen, Anne S. De Groot, Christine S. Rollier, Mark C. Poznansky	14
6	Multiple clinically relevant immunotherapies prolong the function of microencapsulated porcine islet xenografts in diabetic NOD mice without the use of anti‐CD154 mAb 2020 ·Xenotransplantation ·Susan A. Safley, (unknown), Robert W. Holdcraft, Lawrence S. Gazda, (unknown), Mark C. Poznansky, Athanassios Sambanis, Collin J. Weber	6
7	Novel multiparameter correlates of Coxiella burnetii infection and vaccination identified by longitudinal deep immune profiling 2020 ·Scientific Reports ·Patrick M. Reeves, Susan Raju Paul, Laurie A. Baeten, (unknown), (unknown), Joshua M. Hess, (unknown), Anja Scholzen, Anja Garritsen, Anne S. De Groot, Leonard Moise, Timothy Brauns, Richard A. Bowen, Ann E. Sluder, Mark C. Poznansky	9
8	Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever 2019 ·Infection and Immunity ·Anja Scholzen, Guilhem Richard, Leonard Moise, (unknown), Chantal P. Bleeker‐Rovers, Patrick M. Reeves, Susan Raju Paul, William Martin, Anne S. De Groot, Mark C. Poznansky, Ann E. Sluder, Anja Garritsen	11
9	Intraparenchymal Application of Mature B Lymphocytes Improves Structural and Functional Outcome after Contusion Traumatic Brain Injury 2019 ·Journal of Neurotrauma ·Ruxandra F. Sîrbulescu, Joon Yong Chung, (unknown), (unknown), Mark C. Poznansky, Michael J. Whalen	21
10	Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response 2018 ·The Journal of Immunology ·Yoshifumi Kimizuka, (unknown), Joseph J. Locascio, (unknown), (unknown), Mai Shibata, (unknown), Ruxandra F. Sîrbulescu, (unknown), Patrick M. Reeves, Makoto Suematsu, Jeffrey A. Gelfand, Timothy Brauns, Mark C. Poznansky, Kosuke Tsukada, Satoshi Kashiwagi	22
11	PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4+ TILs in the Presence of PD-L1+ TAMs 2017 ·Cancer Research ·Austin K. Mattox, Jina Lee, William H. Westra, Robert H. Pierce, Ronald Ghossein, William C. Faquin, Thomas Diefenbach, Luc G.T. Morris, Derrick T. Lin, Lori J. Wirth, (unknown), Eiichi Ishida, (unknown), (unknown), Yang Zeng, Huabiao Chen, Mark C. Poznansky, Neil M. Iyengar, Sara I. Pai	76
12	CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer 2011 ·Cancer Research ·Elda Righi, Satoshi Kashiwagi, J. P. Yuan, Michael Santosuosso, Pierre Leblanc, Rachel Ingraham, Benjamin Forbes, (unknown), Brian Collette, Deyin Xing, (unknown), Maria Cristina Mingari, Fabrizio Vianello, Michael J. Birrer, Sandra Oršulić, Glenn Dranoff, Mark C. Poznansky	191
13	The Efficacy of T Cell-Mediated Immune Responses Is Reduced by the Envelope Protein of the Chimeric HIV-1/SIV-KB9 Virus In Vivo 2008 ·The Journal of Immunology ·Liljana Stevceva, (unknown), Angela Carville, Beatriz Pacheco, Michael Santosuosso, Birgit Korioth-Schmitz, Keith G. Mansfield, Mark C. Poznansky	12
14	Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control 2006 ·The Journal of Immunology ·Fabrizio Vianello, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Giorgio Palù, (unknown), (unknown), (unknown), Mark C. Poznansky	8
15	Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control 2006 ·The Journal of Immunology ·Fabrizio Vianello, Natalia Papeta, Tao Chen, P. Kraft, Natasha D. White, William K. Hart, Moritz F. Kircher, Eric F. Swart, (unknown), Giorgio Palù, Daniel Irimia, Mehmet Toner, Ralph Weissleder, Mark C. Poznansky	103
16	A CXCR4-Dependent Chemorepellent Signal Contributes to the Emigration of Mature Single-Positive CD4 Cells from the Fetal Thymus 2005 ·The Journal of Immunology ·Fabrizio Vianello, P. Kraft, (unknown), William K. Hart, Natasha D. White, Mark C. Poznansky	47
17	Thymocyte emigration is mediated by active movement away from stroma-derived factors 2002 ·Journal of Clinical Investigation ·Mark C. Poznansky, Ivona T. Olszak, Richard H. Evans, Zheng‐Yu Wang, Russell B. Foxall, Douglas P. Olson, Kathryn Weibrecht, Andrew D. Luster, David T. Scadden	81
18	The in Vivo Effects of Combination Antiretroviral Drug Therapy on Peripheral Blood CD34+ Cell Colony-Forming Units from HIV Type 1-Infected Patients 1999 ·AIDS Research and Human Retroviruses ·Gregor B. Adams, Alexander S. Pym, Mark C. Poznansky, Myra O. McClure, Jonathan Weber	11
19	Efficiency of a high-titer retroviral vector for gene transfer into skeletal myoblasts 1998 ·Journal of Thoracic and Cardiovascular Surgery ·Reida El Oakley, Nigel J. Brand, Paul Burton, (unknown), Gregor B. Adams, Mark C. Poznansky, Paul J.R. Barton, Magdi H. Yacoub	12
20	2nd European Meeting on Complement in Human Disease 1988 ·(unknown), (unknown), (unknown), Robert B. Sim, Peter Späth, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mark C. Poznansky, P. J. Lachmann, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact